| Oct 4 |
Sector Update: Health Care Stocks Steady Late Afternoon
|
| Oct 4 |
Johnson & Johnson Ends Phase 2 Study For Dengue Antiviral Amid R&D Reprioritization
|
| Oct 4 |
Sanofi Healthcare Bidders Revising Offers Over Talc Concerns
|
| Oct 4 |
Johnson & Johnson halts mid-stage study for dengue antiviral
|
| Oct 4 |
J&J discontinues dengue drug study after changes in R&D portfolio
|
| Oct 4 |
Wells Fargo says there is a risk that Johnson & Johnson will guide lower
|
| Oct 4 |
Opdivo gets ‘perioperative’ approval; pharmas cut jobs in New Jersey, Ireland
|
| Oct 4 |
2 Smart Income Stocks to Buy Right Now
|
| Oct 3 |
Why Johnson & Johnson (JNJ) Dipped More Than Broader Market Today
|
| Oct 2 |
Johnson & Johnson's Options: A Look at What the Big Money is Thinking
|
